Search research articles
Contact Us
Filters
Showing results (171-180 of 229) with videos related to
Page
of 23
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
European School of Oncology. First Euro-American Forum on Lung Cancer Treatment
P A Bunn, N Van Zandwijk, U Pastorino, et al.
European Journal of Pharmacology
|
October 18, 2011
Effects of K201 on repolarization and arrhythmogenesis in anesthetized chronic atrioventricular block dogs susceptible to dofetilide-induced torsade de pointes
Thom R G Stams, Avram Oros, Roel van der Nagel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 8, 2006
A randomised phase II study of two different schedules of pegylated liposomal doxorubicin in metastatic breast cancer (EORTC-10993)
R E Coleman, L Biganzoli, P Canney, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 26, 2001
Phase II study of XR 5000, an inhibitor of topoisomerases I and II, in advanced colorectal cancer
F Caponigro, C Dittrich, J B Sorensen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 28, 2009
An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer
M Schmidt, M E Scheulen, C Dittrich, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 2, 2004
Phase II study of OSI-211 (liposomal lurtotecan) in patients with metastatic or loco-regional recurrent squamous cell carcinoma of the head and neck. An EORTC New Drug Development Group study
F Duffaud, M Borner, P Chollet, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
December 24, 2005
Early results from a phase I study on orally administered tris(8-quinolinolato)gallium(III) (FFC11, KP46) in patients with solid tumors--a CESAR study (Central European Society for Anticancer Drug Research--EWIV)
R D Hofheinz, C Dittrich, M A Jakupec, et al.
The American Journal of Cardiology
|
October 1, 1993
Mitral regurgitation associated with reduced thromboembolic events in high-risk patients with nonrheumatic atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators
J L Blackshear, L A Pearce, R W Asinger, et al.
The American Journal of Cardiology
|
September 15, 1990
Transesophageal echocardiography in the evaluation of prosthetic and native aortic valves
H C Dittrich, H A McCann, T P Walsh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 27, 2016
ESMO/ASCO recommendations for a Global Curriculum (GC) in medical oncology-edition 2016
C Dittrich, M Kosty, S Jezdic, et al.
Page
of 23
Search research articles
Search
Showing results (171-180 of 229) with videos related to
Sort By:
Page
of 23
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
European School of Oncology. First Euro-American Forum on Lung Cancer Treatment
P A Bunn, N Van Zandwijk, U Pastorino, et al.
European Journal of Pharmacology
|
October 18, 2011
Effects of K201 on repolarization and arrhythmogenesis in anesthetized chronic atrioventricular block dogs susceptible to dofetilide-induced torsade de pointes
Thom R G Stams, Avram Oros, Roel van der Nagel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 8, 2006
A randomised phase II study of two different schedules of pegylated liposomal doxorubicin in metastatic breast cancer (EORTC-10993)
R E Coleman, L Biganzoli, P Canney, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 26, 2001
Phase II study of XR 5000, an inhibitor of topoisomerases I and II, in advanced colorectal cancer
F Caponigro, C Dittrich, J B Sorensen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 28, 2009
An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer
M Schmidt, M E Scheulen, C Dittrich, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 2, 2004
Phase II study of OSI-211 (liposomal lurtotecan) in patients with metastatic or loco-regional recurrent squamous cell carcinoma of the head and neck. An EORTC New Drug Development Group study
F Duffaud, M Borner, P Chollet, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
December 24, 2005
Early results from a phase I study on orally administered tris(8-quinolinolato)gallium(III) (FFC11, KP46) in patients with solid tumors--a CESAR study (Central European Society for Anticancer Drug Research--EWIV)
R D Hofheinz, C Dittrich, M A Jakupec, et al.
The American Journal of Cardiology
|
October 1, 1993
Mitral regurgitation associated with reduced thromboembolic events in high-risk patients with nonrheumatic atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators
J L Blackshear, L A Pearce, R W Asinger, et al.
The American Journal of Cardiology
|
September 15, 1990
Transesophageal echocardiography in the evaluation of prosthetic and native aortic valves
H C Dittrich, H A McCann, T P Walsh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 27, 2016
ESMO/ASCO recommendations for a Global Curriculum (GC) in medical oncology-edition 2016
C Dittrich, M Kosty, S Jezdic, et al.
Page
of 23